Comment on "Hypometabolic gliomas on FET-PET-is there an inverted U-curve for survival?"
Neuro Oncol
.
2019 Dec 17;21(12):1612-1613.
doi: 10.1093/neuonc/noz173.
Authors
Norbert Galldiks
1
2
3
,
Antoine Verger
4
,
Timothée Zaragori
4
,
Marcus Unterrainer
5
,
Bogdana Suchorska
6
,
Philipp Lohmann
2
,
Jörg C Tonn
6
,
Karl-Josef Langen
2
3
7
,
Nathalie L Albert
5
Affiliations
1
Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
2
Institute of Neuroscience and Medicine, Reseach Center Juelich, Juelich, Germany.
3
Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Düsseldorf, Germany.
4
Department of Nuclear Medicine and Nancyclotep Imaging Platform, Regional University Hospital Center, Lorraine University, Nancy, France.
5
Department of Nuclear Medicine, University Hospital, Ludwig Maximilians University of Munich, Munich, Germany.
6
Department of Neurosurgery, University Hospital, Ludwig Maximilians University of Munich, Munich, Germany.
7
Department of Nuclear Medicine, University of Aachen, Aachen, Germany.
PMID:
31504819
PMCID:
PMC6917398
DOI:
10.1093/neuonc/noz173
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Brain Neoplasms*
Glioma*
Humans
Positron-Emission Tomography